AU2004234110A1 - Heterocyclic compounds for use in the treatment of viral infections - Google Patents

Heterocyclic compounds for use in the treatment of viral infections Download PDF

Info

Publication number
AU2004234110A1
AU2004234110A1 AU2004234110A AU2004234110A AU2004234110A1 AU 2004234110 A1 AU2004234110 A1 AU 2004234110A1 AU 2004234110 A AU2004234110 A AU 2004234110A AU 2004234110 A AU2004234110 A AU 2004234110A AU 2004234110 A1 AU2004234110 A1 AU 2004234110A1
Authority
AU
Australia
Prior art keywords
furo
alkyl
decyl
pyrimidin
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004234110A
Other languages
English (en)
Inventor
Jan Balzarini
Erik De Clercq
Christopher Mcguigan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rega Foundation
University College Cardiff Consultants Ltd
Original Assignee
Rega Foundation
University College Cardiff Consultants Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rega Foundation, University College Cardiff Consultants Ltd filed Critical Rega Foundation
Publication of AU2004234110A1 publication Critical patent/AU2004234110A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2004234110A 2003-04-25 2004-04-21 Heterocyclic compounds for use in the treatment of viral infections Abandoned AU2004234110A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0309506 2003-04-25
GB0309506.4 2003-04-25
PCT/GB2004/001687 WO2004096813A1 (en) 2003-04-25 2004-04-21 Heterocyclic compounds for use in the treatment of viral infections

Publications (1)

Publication Number Publication Date
AU2004234110A1 true AU2004234110A1 (en) 2004-11-11

Family

ID=33397005

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004234110A Abandoned AU2004234110A1 (en) 2003-04-25 2004-04-21 Heterocyclic compounds for use in the treatment of viral infections

Country Status (7)

Country Link
US (1) US20070191373A1 (https=)
EP (1) EP1622913A1 (https=)
JP (1) JP2006524672A (https=)
AU (1) AU2004234110A1 (https=)
CA (1) CA2523739A1 (https=)
MX (1) MXPA05010802A (https=)
WO (1) WO2004096813A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083923A (en) * 1997-10-31 2000-07-04 Isis Pharmaceuticals Inc. Liposomal oligonucleotide compositions for modulating RAS gene expression
EP2318415B1 (en) 2008-07-15 2013-02-20 Sanofi Oxazolopyrimidines as edg-1 receptor agonists
AR079980A1 (es) 2010-01-13 2012-03-07 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2,5,7
AR079981A1 (es) 2010-01-13 2012-03-07 Sanofi Aventis Derivados de acido carboxilico que comprenden un anillo de oxoazolopirimidina 2,5,7- sustituido
CN102834400B (zh) * 2010-01-14 2015-06-10 赛诺菲 2,5-取代的*唑并嘧啶衍生物
CN102791717B (zh) * 2010-01-14 2016-03-30 赛诺菲 具有2,5-取代的噁唑并嘧啶环的羧酸衍生物
AR082453A1 (es) 2010-04-21 2012-12-12 Novartis Ag Compuestos de furopiridina, composiciones farmaceuticas que los contienen y usos de los mismos
GB201111779D0 (en) 2011-07-08 2011-08-24 Univ Cardiff Chemical compounds
WO2014140077A1 (en) 2013-03-14 2014-09-18 Glaxosmithkline Intellectual Property (No.2) Limited Furopyridines as bromodomain inhibitors
BR112022025710A2 (pt) 2020-06-19 2023-03-07 Bayer Ag 1,3,4-oxadiazol pirimidinas e 1,3,4-oxadiazol piridinas como fungicidas

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2444148A1 (en) * 2001-04-11 2002-10-24 Queen's University At Kingston Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents

Also Published As

Publication number Publication date
EP1622913A1 (en) 2006-02-08
WO2004096813A1 (en) 2004-11-11
JP2006524672A (ja) 2006-11-02
MXPA05010802A (es) 2005-12-14
CA2523739A1 (en) 2004-11-11
US20070191373A1 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
AU737902B2 (en) Anti-viral pyrimidine nucleoside analogues
DE69021242T2 (de) Antivirale Verbindungen.
JP2743099B2 (ja) 炭素環状ヌクレオシドおよびヌクレオチド
NL9300058A (nl) 1,5-anhydrohexitol nucleoside analoga en farmaceutisch gebruik daarvan.
IE58334B1 (en) Antiviral guanine derivatives
MXPA97002488A (en) Compounds of purine and guanine as inhibitors of
NZ526632A (en) Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
CH676712A5 (https=)
EP0502690B1 (en) Cyclopropane derivative
AU2004234110A1 (en) Heterocyclic compounds for use in the treatment of viral infections
PL150841B1 (en) Purine compounds.
AU3760793A (en) Antiviral phosphonic acid derivatives of purine analogues
CN1921867B (zh) 用于治疗hiv感染的膦酸核苷衍生物
GB2073752A (en) 2,6-diaminobularines
AU617724B2 (en) 9-(2-(Phosphonomethoxy)Ethoxy) Purine derivatives, intermediates and use as pharmaceuticals
EP0061283A1 (en) Antiviral agents, their preparation and use
WO2021038540A1 (en) Cycloalkylidene carboxylic acids and derivatives as btk inhibitors
NZ225089A (en) 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives and pharmaceutical compositions
EP0110575A1 (en) 1-Aroyl-5-oxo-2-pyrrolidinepropanoic acids and related esters
US5126347A (en) Isomeric dideoxynuclesides
ES2226647T3 (es) Proceso para la preparacion de derivados de vinil pirimidina.
WO1995015964A1 (en) Nucleoside derivative
US5457091A (en) N1-substituted 1H-1,2,3-triazolo[4,5,-D]pyrimidines, a process for their preparation and their use as antiviral agents
KR100225457B1 (ko) 항암 효과가 있는 새로운 피롤리진 유도체, 그의 염 및 그들의 용매 화합물 그리고 그들의 제조방법
MXPA99009965A (en) Anti-viral pyrimidine nucleoside analogues

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application